Tata Chemicals Surges Nearly 12% on Tata Sons Listing Hopes
Shares of Tata Chemicals Limited surged as much as 11.90% to an intraday high of Rs 772.00 on NSE on 13 April, extending gains for the fourth straight session, as renewed hopes of parent company Tata Sons listing as a public entity stoked value unlocking expectations among shareholders. The rally... The post Tata Chemicals Surges Nearly 12% on Tata Sons Listing Hopes appeared first on Equitypandit.
Shares of Tata Chemicals Limited surged as much as 11.90% to an intraday high of Rs 772.00 on NSE on 13 April, extending gains for the fourth straight session, as renewed hopes of parent company Tata Sons listing as a public entity stoked value unlocking expectations among shareholders.
The rally is driven by speculation that a Tata Sons listing could unlock value for group companies. Tata Chemicals held 10,237 securities in Tata Sons as per its 2025 annual report. Tata Sons is currently classified as an upper-layer NBFC under RBI norms, which mandates it to list.
The company had cleared debt of Rs 22,000 crore by March 2024 in an attempt to seek exemption from this classification. As per latest draft RBI amendment directions, the central bank has proposed scrapping the parametric scoring model for upper-layer NBFC classifications.
The stock has gained in six out of the last eight trading sessions, clocking cumulative gains of 32% during that period, making Monday’s move the biggest single-day rise since March 2024.On a consolidated basis, Tata Chemicals posted a net loss of Rs 69 crore in Q3FY26 on total income of Rs 3,588 crore, as per its unaudited financial results filed with NSE.
At 11:47 am, shares were up 5.67% at Rs 729.05 on NSE, off the session high. The stock is down 12.40% over the past year and has shed 2.94% year to date. Its 52-week high stands at Rs 1,026.65, hit in September 2025, while its 52-week low of Rs 580.30 was recorded on 30 March 2026.
The post Tata Chemicals Surges Nearly 12% on Tata Sons Listing Hopes appeared first on Equitypandit.
What's Your Reaction?
